Michael D. Geschwind

17.6k total citations · 4 hit papers
132 papers, 7.4k citations indexed

About

Michael D. Geschwind is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Michael D. Geschwind has authored 132 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 65 papers in Neurology and 34 papers in Neurology. Recurrent topics in Michael D. Geschwind's work include Prion Diseases and Protein Misfolding (73 papers), Neurological diseases and metabolism (30 papers) and Autoimmune Neurological Disorders and Treatments (24 papers). Michael D. Geschwind is often cited by papers focused on Prion Diseases and Protein Misfolding (73 papers), Neurological diseases and metabolism (30 papers) and Autoimmune Neurological Disorders and Treatments (24 papers). Michael D. Geschwind collaborates with scholars based in United States, Italy and United Kingdom. Michael D. Geschwind's co-authors include Bruce L. Miller, Michael Erkkinen, Howard J. Federoff, Aissa Haman, Huidy Shu, Alfred I. Geller, Leonel Tadao Takada, Stephen J. DeArmond, Jeffrey M. Gelfand and Peter Zahos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Michael D. Geschwind

129 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases

2017 753 citations Michael D. Geschwind et al. profile →
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location

2009 560 citations Huidy Shu, Michael D. Geschwind et al. Annals of Neurology profile →
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease

2013 511 citations Keith Vossel, Alexander J. Beagle et al. JAMA Neurology profile →
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

2021 171 citations Brian S. Appleby, Michael D. Geschwind et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Geschwind United States	41	3.7k	3.1k	1.6k	1.5k	1.2k	132	7.4k
Cyrus P. Zabetian United States	54	2.9k 0.8×	5.4k 1.7×	2.1k 1.3×	2.0k 1.3×	2.2k 1.8×	139	9.1k
Haydeh Payami United States	47	2.5k 0.7×	3.7k 1.2×	1.7k 1.1×	1.6k 1.1×	2.6k 2.2×	97	7.4k
Pascal Derkinderen France	47	1.9k 0.5×	3.2k 1.0×	1.5k 0.9×	1.0k 0.7×	1.4k 1.1×	142	7.0k
Jean‐Jacques Martin Belgium	45	3.3k 0.9×	1.6k 0.5×	1.8k 1.1×	1.1k 0.7×	2.7k 2.3×	180	7.2k
Beisha Tang China	52	5.1k 1.4×	3.9k 1.3×	3.7k 2.3×	1.7k 1.1×	1.8k 1.5×	548	10.9k
Olga Pletniková United States	49	4.2k 1.1×	3.5k 1.1×	2.2k 1.4×	1.3k 0.9×	2.8k 2.4×	84	8.9k
Carlo Ferrarese Italy	46	2.0k 0.5×	2.1k 0.7×	1.8k 1.1×	1.1k 0.7×	1.4k 1.2×	302	6.7k
Alberto Rábano Spain	45	3.0k 0.8×	1.1k 0.4×	1.8k 1.1×	1.9k 1.2×	2.7k 2.2×	148	7.7k
Masanori Nakagawa Japan	48	3.0k 0.8×	2.4k 0.8×	1.7k 1.1×	908 0.6×	1.3k 1.1×	324	8.3k
Carolyn M. Sue Australia	55	5.3k 1.4×	2.7k 0.9×	1.7k 1.0×	1.0k 0.7×	1.5k 1.3×	199	9.7k

Countries citing papers authored by Michael D. Geschwind

Since Specialization

Citations

This map shows the geographic impact of Michael D. Geschwind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Geschwind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Geschwind more than expected).

Fields of papers citing papers by Michael D. Geschwind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Geschwind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Geschwind. The network helps show where Michael D. Geschwind may publish in the future.

Co-authorship network of co-authors of Michael D. Geschwind

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Geschwind. A scholar is included among the top collaborators of Michael D. Geschwind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Geschwind. Michael D. Geschwind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tipton, Philip W., Steven Dunham, John C. Morris, et al.. (2025). Standardizing “Rapid”. Neurology. 106(1). e214439–e214439.

Tipton, Philip W., Yuka A. Martens, Steven Dunham, et al.. (2023). Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM₃P Score. Annals of Neurology. 95(2). 237–248. 6 indexed citations

Lawrence, Jessica, Katrin Soldau, Donald Pizzo, et al.. (2022). Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus. Neurobiology of Disease. 172. 105834–105834. 7 indexed citations

Yao, Jingwen, Melanie A. Morrison, Angela Jakary, et al.. (2022). Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease. NeuroImage. 265. 119788–119788. 8 indexed citations

Younes, Kyan, Julio C. Rojas, Amy Wolf, et al.. (2021). Selective vulnerability to atrophy in sporadic Creutzfeldt‐Jakob disease. Annals of Clinical and Translational Neurology. 8(6). 1183–1199. 7 indexed citations

Guo, Chu‐Yueh, Jeffrey M. Gelfand, & Michael D. Geschwind. (2020). Anti-gamma-aminobutyric acid receptor type A encephalitis: a review. Current Opinion in Neurology. 33(3). 372–380. 15 indexed citations

Figueroa, Karla P., Susan Perlman, George Wilmot, et al.. (2020). The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism & Related Disorders. 72. 37–43. 16 indexed citations

Vallabh, Sonia M., Chloe K. Nobuhara, Franc Llorens, et al.. (2019). Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proceedings of the National Academy of Sciences. 116(16). 7793–7798. 27 indexed citations

Aguilar‐Calvo, Patricia, Alejandro M. Sevillano, Katrin Soldau, et al.. (2019). Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions. Acta Neuropathologica. 139(3). 527–546. 18 indexed citations

10.

Figueroa, Karla P., Stefan M. Pulst, Susan Perlman, et al.. (2019). Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. The Cerebellum. 18(3). 519–526. 13 indexed citations

11.

Takada, Leonel Tadao, K. H. Wong, Sven Forner, et al.. (2016). Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 174(1). 36–69. 66 indexed citations

12.

Gelfand, Jeffrey M., Carolyn Fredericks, Matteo Paoletti, et al.. (2016). Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182). Neurology. 86(16_supplement). 2 indexed citations

13.

Calì, Ignazio, et al.. (2015). Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone. Acta Neuropathologica Communications. 3(1). 37–37. 18 indexed citations

14.

Höftberger, Romana, Agnes van Sonderen, Frank Leypoldt, et al.. (2015). Encephalitis and AMPA receptor antibodies. Neurology. 84(24). 2403–2412. 243 indexed citations

15.

Tousseyn, Thomas, Henry Sánchez, Abby Oehler, et al.. (2015). Prion Disease Induces Alzheimer Disease—Like Neuropathologic Changes. Journal of Neuropathology & Experimental Neurology. 74(9). 873–888. 27 indexed citations

16.

Lanata, Serggio, Pierluigi Gambetti, & Michael D. Geschwind. (2014). Wernicke-Korsakoff Syndrome Mimicking Sporadic Jakob-Creutzfeldt Disease (P5.235). Neurology. 82(10_supplement). 1 indexed citations

17.

Vossel, Keith, Alexander J. Beagle, Gil D. Rabinovici, et al.. (2013). Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease. JAMA Neurology. 70(9). 1158–1158. 511 indexed citations breakdown →

18.

Geschwind, Michael D., et al.. (2013). Ethics in prion disease. Progress in Neurobiology. 110. 29–44. 14 indexed citations

19.

Almeida, Sandra, Zhijun Zhang, Giangennaro Coppola, et al.. (2012). Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal Defects. Cell Reports. 2(5). 1471–1471. 3 indexed citations

20.

Benetti, Federico, Michael D. Geschwind, & Giuseppe Legname. (2010). De novo prions. F1000 Biology Reports. 2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact